Loading company…
Matter Bio develops biotechnology focused on preserving and repairing genome integrity.
Founded in 2022 and based in Delaware, US, Matter Bioworks develops biotechnology focused on genome integrity and information loss. Its work includes DNA editing, mutation detection, and immune therapies through its subsidiaries Spellcheck Bio, MutagenTech, and Loki Therapeutics. The company was co-founded by CEO Chris Bradley and Sam Sharifi. In October 2023, it raised venture funding led by LifeSpan Vision Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in